Gerresheimer

Gerresheimer

Gerresheimer: Partner for the pharma and healthcare industry.

Launch date
Employees
Market cap
€3.6b
Enterprise valuation
€4.6b (Public information from Sep 2024)
Düsseldorf Nordrhein-Westfalen (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues1.4b1.5b1.8b2.0b2.1b2.4b2.7b
% growth-6 %21 %10 %6 %16 %10 %
EBITDA324m325m390m418m438m551m620m
% EBITDA margin23 %22 %21 %21 %21 %23 %23 %
Profit88.6m83.8m96.1m116m141m195m241m
% profit margin6 %6 %5 %6 %7 %8 %9 %
EV / revenue2.8x1.9x1.8x2.0x2.2x1.9x1.7x
EV / EBITDA12.4x8.8x8.5x9.4x10.4x8.2x7.2x
R&D budget7.7m10.0m21.6m16.1m---
R&D % of revenue1 %1 %1 %1 %---
  • Edit
DateInvestorsAmountRound

N/A

Acquisition
N/A

N/A

IPO
*
N/A

€272m

Private Placement non VC
Total Funding-

Recent News about Gerresheimer

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Gerresheimer

Edit
Sensile Medical
ACQUISITION by Gerresheimer Jul 2018
Blitz LuxCo
ACQUISITION by Gerresheimer May 2024